Wendell P. Weeks net worth and biography

Wendell Weeks Biography and Net Worth

Director of Merck & Co., Inc.

Mr. Wendell P. Weeks has been the Chief Executive Officer and President of Corning Incorporated since April 26, 2005 and December 2010 respectively and has been its Chairman since April 26, 2007. Mr. Weeks has been an Executive Director of Corning Incorporated since December 2000. Mr. Weeks has 32 years of Corning experience including financial management, business development, commercial leadership and general management. His experiences in many of Corning's businesses and technologies and 11 years as Chief Executive Officer, have given him a unique understanding of Corning's diverse business operations and innovations. He served as the Chairman and Chief Executive Officer of Dow Corning Corporation since April 26, 2007. He served as the President of Corning Incorporated from 2002 to April 2007 and served as its Chief Operating Officer from 2002 to April 28, 2005. Since 2001, he served as the President of Corning's Optical Communications Group, where he helped restructure the business during one of the toughest economic downturns in the telecommunications industry and also served as its Chief Operating Officer since 2002. Mr. Weeks joined Corning in 1983 and served as its Vice President and Deputy General Manager of the Opto-Electronics Components Business since 1995, Vice President and General Manager of Telecommunications Products since 1996, Senior Vice President since 1997, Senior Vice President of Opto-Electronics since 1998, Executive Vice President of Optical Communications since 1999 and President of Corning Optical Technologies since 2001. He served as a Staff Accountant of Price Waterhouse. He has been an Independent Director of Merck & Co., Inc. since February 24, 2004. He has been a Director of Amazon.com, Inc. since February 10, 2016. He serves as a Director of the Corning Museum of Glass and the Corning Incorporated Foundation. He served as a Director of Dow Corning Corporation since 2000. Mr. Weeks holds an MBA from Harvard Business School in 1987 as a Baker Scholar and a Bachelor's degree in Accounting and Finance from Lehigh University in 1981.

What is Wendell P. Weeks' net worth?: The estimated net worth of Wendell P. Weeks is at least $74.63 million as of July 26th, 2023. Mr. Weeks owns 847,474 shares of Merck & Co., Inc. stock worth more than $74,626,865 as of March 26th. This net worth estimate does not reflect any other investments that Mr. Weeks may own. Learn More about Wendell P. Weeks' net worth.
How do I contact Wendell P. Weeks?: The corporate mailing address for Mr. Weeks and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Wendell P. Weeks' contact information.
Has Wendell P. Weeks been buying or selling shares of Merck & Co., Inc.?: Wendell P. Weeks has not been actively trading shares of Merck & Co., Inc. over the course of the past ninety days. Most recently, Wendell P. Weeks sold 5,000 shares of the business's stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $76.02, for a transaction totalling $380,100.00. Following the completion of the sale, the director now directly owns 5,100 shares of the company's stock, valued at $387,702. Learn More on Wendell P. Weeks' trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 2/6/2025.

Wendell P. Weeks Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/7/2020	Sell	5,000	$76.02	$380,100.00	5,100
2/13/2019	Sell	5,000	$78.71	$393,550.00	5,100
2/9/2018	Sell	5,000	$53.57	$267,850.00	5,100
2/6/2017	Sell	5,000	$64.51	$322,550.00	5,100
11/4/2015	Sell	5,000	$55.53	$277,650.00	100
11/24/2014	Sell	5,000	$59.13	$295,650.00

Wendell P. Weeks Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $88.06

$87.31

$89.32

50 Day Range

MA: $92.35

$83.01

$100.72

2 Week Range

Now: $88.06

$81.04

$134.63

Volume

13,807,591 shs

Average Volume

10,313,465 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35